As of 2025-04-23, the Relative Valuation of Organogenesis Holdings Inc (ORGO) is 0.24 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.33 USD, the upside of Organogenesis Holdings Inc based on Relative Valuation is -94.5%.
The range of the Relative Valuation is 0.11 - 0.40 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 29.1x | 23.2x |
| Forward P/E multiples | 14.5x - 23.5x | 18.5x |
| Fair Price | 0.11 - 0.40 | 0.24 |
| Upside | -97.5% - -90.7% | -94.5% |
| Date | P/E |
| 2025-04-21 | 620.16 |
| 2025-04-17 | 621.63 |
| 2025-04-16 | 626.05 |
| 2025-04-15 | 636.36 |
| 2025-04-14 | 637.83 |
| 2025-04-11 | 627.52 |
| 2025-04-10 | 552.40 |
| 2025-04-09 | 601.01 |
| 2025-04-08 | 545.03 |
| 2025-04-07 | 573.02 |
| 2025-04-04 | 570.07 |
| 2025-04-03 | 599.53 |
| 2025-04-02 | 640.78 |
| 2025-04-01 | 630.47 |
| 2025-03-31 | 636.36 |
| 2025-03-28 | 662.87 |
| 2025-03-27 | 687.92 |
| 2025-03-26 | 691.60 |
| 2025-03-25 | 768.93 |
| 2025-03-24 | 798.40 |
| 2025-03-21 | 718.85 |
| 2025-03-20 | 718.85 |
| 2025-03-19 | 746.84 |
| 2025-03-18 | 735.05 |
| 2025-03-17 | 732.11 |
| 2025-03-14 | 738.00 |
| 2025-03-13 | 773.35 |
| 2025-03-12 | 774.83 |
| 2025-03-11 | 780.72 |
| 2025-03-10 | 755.68 |
| 2025-03-07 | 759.36 |
| 2025-03-06 | 830.07 |
| 2025-03-05 | 885.31 |
| 2025-03-04 | 742.42 |
| 2025-03-03 | 796.92 |
| 2025-02-28 | 914.77 |
| 2025-02-27 | 452.23 |
| 2025-02-26 | 478.74 |
| 2025-02-25 | 472.85 |
| 2025-02-24 | 468.43 |
| 2025-02-21 | 472.85 |
| 2025-02-20 | 497.89 |
| 2025-02-19 | 519.99 |
| 2025-02-18 | 537.66 |
| 2025-02-14 | 545.03 |
| 2025-02-13 | 542.08 |
| 2025-02-12 | 539.14 |
| 2025-02-11 | 531.77 |
| 2025-02-10 | 525.88 |
| 2025-02-07 | 509.68 |